1 / 7

In-Vitro Diagnostics (IVD) Quality Control Market trends, analysis and forecast to 2026

High prevalence of target diseases, unhealthy lifestyle, product launches, increasing strategic developments such as partnerships and agreements are key factors contributing to high CAGR of In-Vitro Diagnostics (IVD) Quality Control Market during forecast period.

Ptsoniya
Download Presentation

In-Vitro Diagnostics (IVD) Quality Control Market trends, analysis and forecast to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In-Vitro Diagnostics (IVD) Quality Control Market To Reach USD 1229.3 Million By 2026

  2. Market Summary High prevalence of target diseases, unhealthy lifestyle, product launches, increasing strategic developments such as partnerships and agreements are key factors contributing to high CAGR of In-Vitro Diagnostics (IVD) Quality Control Market during forecast period. Market Size – USD 881.8 Million in 2018, Market Growth - CAGR of 4.3%. Market Trends – Product launches and research for In-Vitro Diagnostics (IVD) Quality Control Market.

  3. Our Approach Our Approach Market Summary According to the current analysis of Reports and Data, the global In-Vitro Diagnostics (IVD) Quality Control Market was valued at USD 881.8 Million in 2018 and is expected to reach USD 1229.3 Million by year 2026, at a CAGR of 4.3%. IVD quality controls are tests used to authenticate the consistency of IVD testing system to confirm precision of test findings and assess the influence of factors such as environmental conditions and operator’s performance on test results. Key recent developments: in June 2019, Illumina, Inc. announced the launch of VeriSeq NIPT Solution v2, a CE-IVD; next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT), delivers the most comprehensive view of the fetal genome compared to other CE-IVD NIPT products. Factors including increasing prevalence of chronic diseases, launch of new clinical laboratories, stringent mandates, as well as rising need of early diagnostics by patients drive the growth of In-Vitro Diagnostics (IVD) Quality Control market. Get a Free Sample PDF Report to understand our report before you purchase: https://www.reportsanddata.com/sample-enquiry-form/1508

  4. Our Approach Our Approach Market Summary Some of the key players are Agilent Diagnostics, Abbott Diagnostics, Becton, Dickson and Company, Bio-Rad Laboratories, Inc., and ThermoFisher Scientific Further key findings from the report suggest: • The American Clinical Laboratory Association (ACLA) states that more than 7.5 billion lab tests are performed in U.S. annually and 80% of clinical decisions are taken after lab testing • In December 2018, BioMérieux announced its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for quality control testing of leukocyte-reduced apheresis platelet (LRAP) units with the BACT/ALERT® VIRTUO® fully automated blood culture system • In-Vitro Diagnostics (IVD) Quality Control Market is fastest growing at a CAGR of 3% in Asia Pacific owing to rising incidence of IVD tests in developing countries such as India and China due to upsurge in number of clinical laboratories, global awareness among patients…Continued

  5. Our Approach Our Approach Market Summary Product Type (Revenue, USD Million; 2016–2026) Quality Controls • Whole Blood-based Controls • Serum-based Controls • Plasma-based Controls • Urine-based Controls • Other IVD Quality Controls Data Management Solutions Quality Assurance Services Manufacturer Type (Revenue, USD Million; 2016–2026) Instrument Manufacturer Controls Independent Manufacturer Controls • Third-party Controls • Instrument Specific Manufacturer Controls

  6. Our Approach Our Approach Market Summary Application (Revenue, USD Million; 2016–2026) Clinical Chemistry Immunochemistry Haematology Molecular Diagnostics Coagulation/Haemostasis Microbiology Others End User (Revenue, USD Million; 2016–2026) Hospitals Clinical Laboratories Home Care Others Order Now @ https://www.reportsanddata.com/checkout-form/1508

  7. Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related